p21(ras)-mediated decrease of the retinoblastoma protein in fibroblasts occurs through growth factor-dependent mechanisms

Cell Growth and Differentiation

Volumn 7, Issue 12, 1996, Pages 1705-1712

  Kivinen, Laura ^a   Tiihonen, Erja ^a   Haapajärvi, Tarja ^a   Laiho, Marikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE; CYCLINE; ELONGATION FACTOR 2; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; MESSENGER RNA; METALLOPROTEINASE INHIBITOR; MYC PROTEIN; ORNITHINE DECARBOXYLASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P21; RAS PROTEIN; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; ANTINEOPLASTIC AGENT; GROWTH PROMOTOR; HRAS PROTEIN, HUMAN; PLASMA PROTEIN; PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL GROWTH; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSFORMATION; GENETICS; HUMAN; IMMUNOBLOTTING; METABOLISM; MUTAGENESIS; PHYSIOLOGY;

ANIMALIA; MURINAE;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; CELL CYCLE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; IMMUNOBLOTTING; MICE; MUTAGENESIS; PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENE PROTEINS P21(RAS); RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMATION, GENETIC;

EID: 0029658129     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Kivinen, L., Pitkänen, K., and Laiho, M. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts. Oncogene, 8: 2703-2711, 1993.
2. Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res., 49: 4682-4689, 1989.
3. ras in receptor tyrosine kinase signaling. Crit. Rev. Oncogen., 4: 615-661, 1993.
4. Hall, A. A biochemical function for Ras - at last. Science (Washington DC), 264: 1413-1414, 1994.
5. Waskiewicz, A. J., and Cooper, J. A. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell Biol., 7: 798-805, 1995.
6. Pawson, T. Protein modules and signalling networks. Nature (Lond.), 373: 573-580, 1995.
7. 1 phase in BALB/c 3T3 cells. Mol. Cell. Biol., 14: 5441-5449, 1994.
8. 1 phase of the cell cycle in BALB/c murine fibroblasts. Proc. Natl. Acad. Sci. USA, 89: 3889-3893, 1992.
9. Hagag N., Halegoua, S., and Viola, M. Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21. Nature (Lond.), 319: 680-682, 1986.
10. Tuck, A. B., Wilson, S. M., Khokha, R., and Chambers, A. F. Different patterns of gene expression in ras-resistant and ras-sensitive cells. J. Natl. Cancer Inst., 83: 485-491, 1991.
11. val12 oncogene in transformed cell clones. Exp. Cell Res., 168: 518-530, 1987.
12. Schalken, J. A., Ebeling, S. B., Isaacs, J. T., Treiger, B., Bussemakers, M. J. G., de Jong, M. E. M., and Van den Ven, W. J. M. Down modulation of fibronectin messenger RNA in metastasizing cancer cells revealed by differential hybridization analysis. Cancer Res., 48: 2042-2046, 1988.
13. Chandler, L. A., Ehretsman, C. P., and Bourgeois, S. A novel mechanism of Ha-ras oncogene action: regulation of fibronectin mRNA levels by a nuclear transcriptional event. Mol. Cell. Biol., 14: 3085-3093, 1994.
14. Slack, J. L., Parker, M. I., Robinson, V. R., and Bornstein, P. Regulation of collagen I gene expression by ras. Mol. Cell. Biol., 12: 4714-4723, 1992.
15. Chambers, A. F., Colella, R., Denhardt, D. T., and Wilson, S. M. Increased expression of cathepsins L and B, and decreased activity of their inhibitors, in metastatic ras-transformed NIH 3T3 cells. Mol. Carcinog., 5: 238-245, 1992.
16. Kirjavainen, J., Leppä, S., Hynes, N. E., and Jalkanen, M. Translational suppression of syndecan-1 expression in Ha-ras transformed mouse mammary epithelial cells. Mol. Biol. Cell, 4: 849-858, 1993.
17. Chambers, A. F., and Tuck, A. B. Ras-responsive genes and tumor metastasis. Crit. Rev. Oncogen., 4: 95-114, 1993.
18. Hölttä, E., Sistonen, L., and Alitalo, K. The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. J. Biol. Chem., 263: 4500-4507, 1988.
19. C-Ha-ras oncoprotein includes stimulation of jun gene expression. EMBO J., 8: 815-822, 1989.
20. Stacey, D. W., Watson, T., Kung, H. F., and Curran, T. Microinjection of transforming ras protein induces c-fos expression. Mol. Cell. Biol., 7: 523-527, 1987.
21. Schönthal, A., Herrlich, P., Rahmsdorf, H. J., and Ponta, H. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell, 54: 325-334, 1988.
22. Chin, K-V., Ueda, K., Pastan, I., and Gottesman, M. M. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science (Washington DC), 255: 459-462, 1992.
23. Geiser, A. G., Kim, S-J., Roberts, A. B., and Sporn, M. B. Characterization of the mouse transforming growth factor-β1 promoter and activation by the Ha-ras oncogene. Mol. Cell. Biol., 11: 84-92, 1991.
24. Binétruy, B., Smeal, T., and Karin, M. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature (Lond.), 351: 122-127, 1991.
25. Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R., and Leder, P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell, 49: 465-475, 1987.
26. Lu, X., Hee Park, S., Thompson, T. C., and Lane, D. P. ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation. Cell, 70: 153-161, 1992.
27. Denko, N. C., Giaccia, A. J., Stringer, J. R., and Stambrook, P. J. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc. Natl. Acad. Sci. USA, 91: 5124-5128, 1994.
28. Schlatter, B., and Waghorne, C. G. Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector. Proc. Natl. Acad. Sci. USA, 89: 9986-9990, 1992.
29. Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., and Oren, M. Wild-type p53 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA, 86: 8763-8767, 1989.
30. Finlay, C. A., Hinds, P. W., and Levine, A. J. The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57: 1083-1093, 1989.
31. Liu, H-S., Scrable, H., Villaret, D. B., Lieberman, M. A., and Stambrook, P. J. Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements. Cancer Res., 52: 983-989, 1992.
32. Pitkänen, K., Kivinen, L., DeCaprio, J. A., and Laiho, M. Expression of the human retinoblastoma gene product in mouse fibroblasts: effects on cell proliferation and susceptibility to transformation. Exp. Cell Res., 207: 99-106, 1993.
33. Müller, H., Lukas, J., Schneider, A., Warthoe, P., Bartek, J., Eilers, M., and Strauss, M. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc. Natl. Acad. Sci. USA, 91: 2945-2949, 1994.
34. Huang, J., Mohammadi, M., Rodrigues, G. A., and Schlessinger, J. Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis. J. Biol. Chem., 270: 5065-5072, 1995.
35. Satoh, T., Nakafuku, M., and Kaziro, Y. Function of Ras as a molecular switch in signal transduction. J. Biol. Chem., 267: 24149-24152, 1992.
36. ras by transforming growth factor β in epithelial cells. J. Biol. Chem., 267: 5029-5031, 1992.
37. 1 growth arrest by transforming growth factor β1 requires cellular ras activity. J. Biol. Chem., 268: 21448-21452, 1993.
38. Yan, Z., Winawer, S., and Friedman, E. Two different signal transduction pathways can be activated by transforming growth factor β1 in epithelial cells. J. Biol. Chem., 269: 13231-13237, 1994.
39. Filmus, J., Zhao, J., and Buick, R. N. Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor beta-1 (TGF-β1) and alters the number and type of TGF-β1 receptors in rat intestinal epithelial cells. Oncogene, 7: 521-526, 1992.
40. Game, S. M., Huelsen, A., Patel, V., Donnelly, M., Yeudall, W. A., Stone, A., Fusenig, N. E., and Prime, S. S. Progressive abrogation of TGF-β1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes. Int. J. Cancer, 52: 461-470, 1992.
41. cdc2 regulation in ras-transfected epithelial cells. Oncogene, 7: 1549-1556, 1992.
42. Benzakour, O., Merzak, A., Dooghe, Y., Pironin, M., Lawrence, D., and Vigier, P. Transforming growth factor-β stimulates mitogenically mouse NIH3T3 fibroblasts and those cells transformed by the EJ-Hras oncogene. Growth Factors, 6: 265-275, 1992.
43. Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., and Matsumoto, K. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science (Washington DC), 270: 2008-2011, 1995.
44. Kawabata, M., Imamura, T., Miyazono, K., Engel, M. E., and Moses, H. L. Interaction of the transforming growth factor-β type I receptor with farnesyl-protein transferase-α. J. Biol. Chem., 270: 29628-29631, 1995.
45. ras famesyltransferase α subunit in TGF-β and activin signaling. Science (Washington DC), 271: 1120-1122, 1996.